Difference between revisions of "Nephrotic syndrome"

From Libre Pathology
Jump to navigation Jump to search
Line 152: Line 152:
***Advanced lesions.
***Advanced lesions.


Image:
Images:
*[http://commons.wikimedia.org/wiki/File:Membranous_Nephropathy_Pathology_Diagram.svg MN - schematic (WC)].
*www:
*[http://www.flickr.com/photos/jian-hua_qiao_md/3989875091/in/set-72157622411941607 MN - silver stain (flickr.com)].
**[http://www.flickr.com/photos/jian-hua_qiao_md/3989875091/in/set-72157622411941607 MN - silver stain (flickr.com)].
*[[WC]]:
**[http://commons.wikimedia.org/wiki/File:Membranous_nephropathy_-_he_-_very_high_mag.jpg MN - very high mag. (WC)].
**[http://commons.wikimedia.org/wiki/File:Membranous_nephropathy_-_pas_-_very_high_mag.jpg MN - PAS - very high mag. (WC)].
**[http://commons.wikimedia.org/wiki/File:Membranous_nephropathy_-_mpas_-_very_high_mag.jpg MN - MPAS - very high mag. (WC)].
**[http://commons.wikimedia.org/wiki/File:Membranous_nephropathy_-_cropped_-_mpas_-_very_high_mag.jpg MN - MPAS - very high mag. (WC)].


===IF===
===IF===

Revision as of 04:09, 9 November 2011

Nephrotic syndrome is a constellation of clinical findings seen in a number of medical kidney diseases. This article deals with them. An introduction to the medical kidney is in the medical kidney diseases article.

In children nephrotic syndrome is assumed to be minimal change disease. Biopsies are done only there is no response to steriods.

Clinical definition

Features:

  • Anasarca (whole body - edema).
  • Proteinuria (>3.5 g/24h).
  • Hypercholesterolemia.
  • Hypoalbuminemia.

Overview

Immune complex negative:

  1. MCD.
  2. FSGS.

Immune complex positive:

  1. MN.
  2. IgA nephropathy.

Specific entities

Minimal change disease

  • Abbreviated MCD.

General

  • Responds to steroids.
  • Most common cause of nephrotic syndrome in children.
  • Onset rapid when compared to FSGS.
  • Proteinuria usually higher in FSGS.

Microscopic

Features:

  • No changes on light microscopy.

EM

Features:

  • Diffuse loss of foot processes.

Note:

  • Foot processes on urinary space side.

Image:

Focal segmental glomerulosclerosis

  • Abbreviated FSGS.

General

  • Presents as nephrotic syndrome.
  • Does not respond to steroids (unlike MCD).

Etiology

  • Primary.
    • May be familial.[1]
  • Secondary.[2]
    • HIV.
    • Drug use.
    • Reduced renal mass.

Primary vs. secondary:[3][4]

Feature Primary Secondary
Proteinuria (onset) sudden progressive
Albumnin low normal
Glomerulus size normal increased
Foot process effacement diffuse mild

Notes:

  • Primary FSGS needs ~70-80% foot process effacement.[3]

Microscopic

Features:

  • Partial sclerosis of less than 50% of glomeruli.
  • +/-Adhesions between the glomerular tuft and Bowman's capsule.

Image:

Histologic classification

FSGS can be subdivided into the following subgroups:[5]

Subtype Comment
Cellular abrupt severe onset
Collapsing poor prognosis, viral/toxic etiology
Tip lesion good prognosis
Perihilar reduced renal mass
Not otherwise specified (NOS) most common

Stains

Features:[6]

  • PAS +ve crescents.

IF

  • No immune deposits.
    • No IgG.
    • No IgA.

Note:

  • IgM, C3 - may be focally positive due to trapping.

EM

  • Foot process loss.
    • Secondary causes tend to have a thinner foot process width.

Membranous nephropathy

  • AKA membranous glomerulonephritis.
  • Abbreviated MN.

General

  • Presents as nephrotic syndrome.
  • Variable course.

Clinical DDx:[7]

  • Hepatitis B.
  • Hepatitis C.
  • Carcinoma.
  • NSAID toxicity.
  • SLE.
  • Idiopathic.

Microscopic

Features:

  • Subepithelial immune complex depositions:
    • Spikes or pinholes - seen on silver stain.
    • +/-Tram-tracking.
      • Advanced lesions.

Images:

IF

  • Diffuse granular capillary loop - IgG, C3, kappa, lambda.

EM

  • Diffuse subepithelial deposits - spike forming.

See also

References

  1. Sánchez de la Nieta MD, Arias LF, Alcázar R, et al. (2003). "[Familial focal and segmentary hyalinosis]" (in Spanish; Castilian). Nefrologia 23 (2): 172–6. PMID 12778884.
  2. URL: http://www.kidneypathology.com/English_version/Focal_segmental_GS.html. Accessed on: 11 February 2011.
  3. 3.0 3.1 D'Agati, V. (Mar 2003). "Pathologic classification of focal segmental glomerulosclerosis.". Semin Nephrol 23 (2): 117-34. doi:10.1053/snep.2003.50012. PMID 12704572. Cite error: Invalid <ref> tag; name "pmid12704572" defined multiple times with different content
  4. Noël, LH. (1999). "Morphological features of primary focal and segmental glomerulosclerosis.". Nephrol Dial Transplant 14 Suppl 3: 53-7. PMID 10382983.
  5. Thomas, DB.; Franceschini, N.; Hogan, SL.; Ten Holder, S.; Jennette, CE.; Falk, RJ.; Jennette, JC. (Mar 2006). "Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.". Kidney Int 69 (5): 920-6. doi:10.1038/sj.ki.5000160. PMID 16518352.
  6. URL: http://www.kidneypathology.com/English_version/Focal_segmental_GS.html. Accessed on: 11 February 2011.
  7. Klatt, Edward C. (2006). Robbins and Cotran Atlas of Pathology (1st ed.). Saunders. pp. 241. ISBN 978-1416002741.